Posted by Michael Wonder on 23 Aug 2021
Dulaglutide receives Medsafe approval
23 August 2021 - Dulaglutide will be funded from 1 September 2021.
PHARMAC has announced that dulaglutide (Trulicity), a GLP-1 agonist supplied by Eli Lilly, will be funded from 1 September 2021 for patients who meet certain eligibility criteria.
